Ask AI

The HER2 Horizon: The Next Era of HER2‑Targeted Treatment in GI Cancer

Enhance your understanding of HER2 testing and treatment selection to improve outcomes for patients with HER2-positive gastroesophageal adenocarcinoma and biliary tract cancer through an expert-authored ClinicalThought commentary and certified on-demand webcast with accompanying downloadable slides.

Share

Program Content

Activities

HER2 GI Cancer Expert Office Hours
ClinicalThought Expert Office Hours Forum: The Next Era of HER2‑Targeted Treatment in GI Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 16, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc.